StockNews.AI
CDLX
StockNews.AI
215 days

CDLX Investor News: Rosen Law Firm Encourages Cardlytics, Inc. Investors to Inquire About Securities Class Action Investigation - CDLX

1. Rosen Law Firm investigates potential claims against Cardlytics for misleading business info. 2. CDLX's stock dropped 57.1% following a 9% revenue decrease announcement. 3. The class action aims to recover losses for CDLX shareholders without upfront costs.

5m saved
Insight
Article

FAQ

Why Very Bearish?

A significant stock drop of 57.1% indicates severe investor distrust, reminiscent of past scandals.

How important is it?

Legal proceedings could heavily influence investor sentiment and stock performance.

Why Short Term?

Immediate effects on stock due to current investigation; recovery may take time.

Related Companies

CDLX
NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cardlytics, Inc. (NASDAQ: CDLX) resulting from allegations that Cardlytics may have issued materially misleading business information to the investing public. So What: If you purchased Cardlytics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=33595 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. What is this about: On August 7, 2024, after market hours, Cardlytics announced its results for the second quarter of 2024. In pertinent part, Cardlytics announced a 9% year-over-year revenue decrease. Commenting on these results, the announcement quoted Cardlytics' Chief Financial Officer as saying that "[w]hile we observed strong growth in redemptions, our results were challenged by slower-than-anticipated billings growth coupled with higher consumer incentives[.] We remain confident that our improved balance sheet continues to support investment in the business." On this news, the price of Cardlytics stock fell 57.1% on August 8, 2024. Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq.      Phillip Kim, Esq.      The Rosen Law Firm, P.A.      275 Madison Avenue, 40th Floor      New York, NY 10016      Tel: (212) 686-1060      Toll Free: (866) 767-3653      Fax: (212) 202-3827      [email protected]      www.rosenlegal.com SOURCE THE ROSEN LAW FIRM, P. A.

Related News